查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678527

全球肿瘤消融市场：市场规模、份额、趋势分析（按技术、治疗方法、应用和地区）、细分市场预测（2025-2030 年）

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Radiofrequency, Microwave), By Treatment (Surgical, Laparoscopic), By Application (Liver Cancer), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

肿瘤消融市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球肿瘤消融市场规模预计到 2030 年将达到 40.8 亿美元，预计 2025 年至 2030 年的复合年增长率为 13.8%。癌症发生率的增加和对有效治疗方案的高需求是推动市场成长的主要因素。根据国际癌症研究机构的数据，2020 年报告了 19,292,789 例癌症病例，预计到 2025 年将达到 50,550,287 例。最常见的癌症是乳癌、肺癌、结肠癌、摄护腺癌和胃癌。由于微创手术具有恢復更快、患者更舒适、所需时间更短等优点，人们的偏好增加，预计将推动先进肿瘤消融手术的需求。

此外，此类设备与超音波、MRI 和 CT 等高效介入成像技术的结合有望彻底改变门诊消融程序。预计这项转变将大幅降低患者的费用，包括住院费用。政府资助的筛检计划、宣传宣传活动和特定癌症计划等倡议预计将增加诊断病例的数量。例如，2019年，英国国家医疗服务体系（NHS）在部分地区启动了肺癌筛检计画。这些倡议预计将增加对早期癌症管理的需求，从而推动市场成长。

肿瘤消融市场报告重点

  • 基于技术，射频肿瘤消融领域将在 2024 年以 32.8% 的最大收入份额引领市场。
  • 按技术划分，经皮消融领域预计将在 2024 年占据最大的收益占有率。
  • 根据应用，其他部分在 2024 年占据了最大的市场占有率。其他部分包括各种类型的癌症，例如骨转移和耳鼻喉癌。
  • 北美占据肿瘤消融市场的主导地位，2024 年的收益占有率最大，为 34.33%。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 肿瘤消融市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 肿瘤消融市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章肿瘤消融市场：按技术分類的估计和趋势分析

  • 定义和范围
    • 射频消融术
    • 微波消融
    • 冷冻疗法
    • 不可逆电穿孔消融
    • HIFU
    • 其他消融技术
  • 按技术分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球肿瘤消融市场：技术展望
  • 市场规模预测及技术趋势分析（2018-2030）
    • 射频消融术
    • 微波消融
    • 冷冻疗法
    • 不可逆电穿孔消融
    • HIFU
    • 其他消融技术

第 5 章肿瘤消融市场：按治疗方法进行的估计和趋势分析

  • 定义和范围
    • 手术消融
    • 腹腔镜消融术
    • 经经皮消融
  • 治疗方法的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球肿瘤消融市场：治疗方法视角
  • 市场规模预测及治疗方法趋势分析（2018-2030）
    • 手术消融
    • 腹腔镜消融术
    • 经经皮消融

第六章肿瘤消融市场：应用估计与趋势分析

  • 定义和范围
    • 肾癌
    • 肝癌
    • 乳癌
    • 肺癌
    • 摄护腺癌
    • 其他癌症
  • 按应用分類的市场占有率（2024 年和 2030 年）
  • 细分仪表板
  • 全球肿瘤消融市场：应用前景
  • 按应用分類的市场规模预测和趋势分析（2018-2030 年）
    • 肾癌
    • 肝癌
    • 乳癌
    • 肺癌
    • 摄护腺癌
    • 其他癌症

第七章肿瘤消融市场：按地区估计和趋势分析

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业市场占有率分析（2024年）
    • Medtronic
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.（Ethicon, Inc.）
    • AngioDynamics
    • Bioventus Inc.（Misonix Inc.）
    • EDAP TMS
    • Chongqing Haifu Medical Technology Co., Ltd
    • Mermaid Medical
    • HealthTronics, Inc.
    • HS Hospital Service SpA
Product Code: 978-1-68038-746-9

Tumor Ablation Market Growth & Trends:

The global tumor ablation market size is estimated to reach USD 4.08 billion by 2030, registering to grow at a CAGR of 13.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Tumor Ablation Market Report Highlights:

  • Based on technology, the radiofrequency tumor ablation segment led the market with the largest revenue share of 32.8% in 2024.
  • Based on technology, the percutaneous ablation segment accounted for the largest revenue share in 2024.
  • Based on application, the other segments accounted for the largest market share in 2024. The other segment includes various types of cancer, such as bone metastasis and ENT cancer.
  • North America dominated the tumor ablation market with the largest revenue share of 34.33% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tumor Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Technological advancements in ablation devices
      • 3.2.1.3. Increasing per capita income
      • 3.2.1.4. Growing demand of minimally invasive surgeries.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Presence of alternative treatment options
  • 3.3. Tumor Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Radiofrequency ablation
    • 4.1.2. Microwave ablation
    • 4.1.3. Cryoablation
    • 4.1.4. Irreversible electroporation ablation
    • 4.1.5. HIFU
    • 4.1.6. Other ablation technologies
  • 4.2. Technology Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tumor Ablation Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Radiofrequency ablation
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Microwave Ablation
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Cryoablation
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Irreversible electroporation ablation
      • 4.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. HIFU
      • 4.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.6. Other ablation technologies
      • 4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgical ablation
    • 5.1.2. Laparoscopic ablation
    • 5.1.3. Percutaneous ablation
  • 5.2. Treatment Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tumor Ablation Market by Treatment Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgical ablation
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Laparoscopic ablation
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Percutaneous ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Kidney cancer
    • 6.1.2. Liver cancer
    • 6.1.3. Breast cancer
    • 6.1.4. Lung cancer
    • 6.1.5. Prostate cancer
    • 6.1.6. Other cancer
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Tumor Ablation Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Kidney cancer
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Liver cancer
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Breast cancer
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Lung cancer
      • 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Prostate cancer
      • 6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Other cancer
      • 6.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. AngioDynamics
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Bioventus Inc. (Misonix Inc.)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. EDAP TMS
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Chongqing Haifu Medical Technology Co., Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mermaid Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. HealthTronics, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. H.S. Hospital Service S.p.A.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 U.S tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 14 Europe tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Europe tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 17 Germany tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Germany tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 UK tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 23 France tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 France tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Italy tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Spain tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 32 Denmark tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 Denmark tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 35 Sweden tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Sweden tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 38 Norway tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 Norway tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 45 China tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 47 China tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 48 Japan tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 50 Japan tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 51 India tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 India tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 54 South Korea tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 South Korea tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 57 Australia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 59 Australia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 60 Thailand tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Thailand tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 63 Latin America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 65 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Brazil tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 72 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 75 Mexico tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 78 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 79 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 80 Mexico tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 81 Argentina tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Argentina tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 83 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 84 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 85 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 86 Argentina tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 87 MEA tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 88 MEA tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 89 MEA tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 90 MEA tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 91 South Africa tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 92 South Africa tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 93 South Africa tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 97 UAE tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 98 UAE tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 99 UAE tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 100 Kuwait tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Kuwait tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 102 Kuwait tumor ablation market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Tumor ablation market: market outlook
  • Fig. 14 Tumor ablation competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Tumor ablation market driver impact
  • Fig. 20 Tumor ablation market restraint impact
  • Fig. 21 Tumor ablation market strategic initiatives analysis
  • Fig. 22 Tumor ablation market: Technology movement analysis
  • Fig. 23 Tumor ablation market: Technology outlook and key takeaways
  • Fig. 24 Radiofrequency ablation market estimates and forecast, 2018 - 2030
  • Fig. 25 Microwave ablation estimates and forecast, 2018 - 2030
  • Fig. 26 Cryoablation market estimates and forecast, 2018 - 2030
  • Fig. 27 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
  • Fig. 28 HIFU market estimates and forecast, 2018 - 2030
  • Fig. 29 Others estimates and forecast, 2018 - 2030
  • Fig. 30 Tumor ablation Market: Treatment Movement Analysis
  • Fig. 31 Tumor ablation market: Treatment outlook and key takeaways
  • Fig. 32 Surgical ablation market estimates and forecast, 2018 - 2030
  • Fig. 33 Percutaneous ablation market estimates and forecast, 2018 - 2030
  • Fig. 34 Laparoscopic ablation market estimates and forecast, 2018 - 2030
  • Fig. 35 Tumor ablation market: application movement analysis
  • Fig. 36 Tumor ablation market: application outlook and key takeaways
  • Fig. 37 Kidney cancer market estimates and forecast, 2018 - 2030
  • Fig. 38 Liver cancer market estimates and forecast, 2018 - 2030
  • Fig. 39 Breast cancer market estimates and forecast, 2018 - 2030
  • Fig. 40 Lung cancer market estimates and forecast, 2018 - 2030
  • Fig. 41 Prostate cancer market estimates and forecast, 2018 - 2030
  • Fig. 42 Other market estimates and forecast, 2018 - 2030
  • Fig. 43 Global tumor ablation market: Regional movement analysis
  • Fig. 44 Global tumor ablation market: Regional outlook and key takeaways
  • Fig. 45 Global tumor ablation market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030
  • Fig. 58 US
  • Fig. 59 US market estimates and forecast, 2018 - 2030
  • Fig. 60 Canada
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecast, 2018 - 2030
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecast, 2018 - 2030
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030
  • Fig. 68 France
  • Fig. 69 France market estimates and forecast, 2018 - 2030
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 76 Sweden
  • Fig. 77 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 82 China
  • Fig. 83 China market estimates and forecast, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030
  • Fig. 86 India
  • Fig. 87 India market estimates and forecast, 2018 - 2030
  • Fig. 88 Thailand
  • Fig. 89 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 92 Australia
  • Fig. 93 Australia market estimates and forecast, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 South Africa
  • Fig. 105 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 108 UAE
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030
  • Fig. 110 Kuwait
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 112 Market share of key market players - Tumor ablation market